Literature DB >> 1131574

Recovery from Goodpasture's syndrome after immunosuppressive treatment and plasmapheresis.

C M Lockwood, J M Boulton-Jones, R M Lowenthal, I J Simpson, D K Peters.   

Abstract

A patient with Goodpasture's syndrome has recovered after treatment with immunosuppressive drugs (cyclophosphamide and prednisolone) and removal of circulating antibodies by plasma exchange. This was performed on seven occasions and seems to have hastened the decline in circulating antibody levels. Undertaken early in the course of the disease plasmapheresis could prove a useful addition to its therapy.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1131574      PMCID： PMC1673280          DOI： 10.1136/bmj.2.5965.252

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


  8 in total

1.  GOODPASTURE'S SYNDROME: A CLINICOPATHOLOGIC ENTITY.

Authors:  F L BENOIT; D B RULON; G B THEIL; P D DOOLAN; R H WATTEN
Journal:  Am J Med       Date:  1964-09       Impact factor: 4.965

2.  Glomerular deposition of properdin in Henoch-Schönlein syndrome and idiopathic focal nephritis.

Authors:  D J Evans; D G Williams; D K Peters; J G Sissons; J M Boulton-Jones; C S Ogg; J S Cameron; B I Hoffbrand
Journal:  Br Med J       Date:  1973-08-11

3.  Anti-glomerular basement membrane antibody-induced glomerulonephritis.

Authors:  C B Wilson; F J Dixon
Journal:  Kidney Int       Date:  1973-02       Impact factor: 10.612

4.  Goodpasture's syndrome: failure of nephrectomy to cure pulmonary hemorrhage.

Authors:  A J Eisinger
Journal:  Am J Med       Date:  1973-10       Impact factor: 4.965

5.  Goodpasture's syndrome: recovery from severe pulmonary hemorrhage after bilateral nephrectomy.

Authors:  A Nowakowski; R B Grove; L H King; T T Antonovych; R W Fortner; M R Knieser; C B Carter; J H Knepshield
Journal:  Ann Intern Med       Date:  1971-08       Impact factor: 25.391

6.  The presence of anti-glomerular basement membrane antibodies in peripheral blood.

Authors:  J J McPhaul; F J Dixon
Journal:  J Immunol       Date:  1969-12       Impact factor: 5.422

7.  Goodpasture's syndrome. Cessation of pulmonary hemorrhage after bilateral nephrectomy.

Authors:  R K Maddock; L E Stevens; K Reemtsma; H A Bloomer
Journal:  Ann Intern Med       Date:  1967-12       Impact factor: 25.391

8.  The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis.

Authors:  R A Lerner; R J Glassock; F J Dixon
Journal:  J Exp Med       Date:  1967-12-01       Impact factor: 14.307
  8 in total
  16 in total

Review 1.  Role of therapeutic plasmapheresis in ANCA-associated vasculitis.

Authors:  Giles Walters
Journal:  Pediatr Nephrol       Date:  2015-05-19       Impact factor: 3.714

Review 2.  Advances in human antiglomerular basement membrane disease.

Authors:  Zhao Cui; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2011-07-19       Impact factor: 28.314

Review 3.  Benefits and limitations of plasmapheresis in renal diseases: an evidence-based approach.

Authors:  Sanjeev Baweja; Kate Wiggins; Darren Lee; Susan Blair; Margaret Fraenkel; Lawrence P McMahon
Journal:  J Artif Organs       Date:  2010-12-10       Impact factor: 1.731

4.  Specificity of kidney-bound antibodies in Goodpasture's syndrome.

Authors:  R Saxena; P Bygren; R Butkowski; J Wieslander
Journal:  Clin Exp Immunol       Date:  1989-10       Impact factor: 4.330

5.  Retrospective study of plasma exchange in patients with idiopathic rapidly progressive glomerulonephritis and vasculitis.

Authors:  A Gianviti; R S Trompeter; T M Barratt; M F Lythgoe; M J Dillon
Journal:  Arch Dis Child       Date:  1996-09       Impact factor: 3.791

6.  Regulation of secondary antibody responses in rodents. I. Potentiation of IgG production by cyclophosphamide.

Authors:  R F Gagnon; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

Review 7.  Advances in apheresis therapy for glomerular diseases.

Authors:  Hitoshi Yokoyama; Takashi Wada; Wei Zhang; Hideki Yamaya; Mitsuhiro Asaka
Journal:  Clin Exp Nephrol       Date:  2007-06-28       Impact factor: 2.801

8.  Plasma exchange improves the glomerulonephritis of systemic lupus erythematosus in selected pediatric patients.

Authors:  S C Jordan; W Ho; R Ettenger; I B Salusky; R N Fine
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

9.  Treatment of non anti-GBM-antibody mediated, rapidly progressive glomerulonephritis by plasmapheresis and immunosuppression.

Authors:  G A Müller; L Seipel; T Risler
Journal:  Klin Wochenschr       Date:  1986-03-03

10.  Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial.

Authors:  Michael Walsh; Peter A Merkel; Chen Au Peh; Wladimir Szpirt; Loïc Guillevin; Charles D Pusey; Janak De Zoysa; Natalie Ives; William F Clark; Karen Quillen; Jeffrey L Winters; Keith Wheatley; David Jayne
Journal:  Trials       Date:  2013-03-14       Impact factor: 2.279
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.